Daniela Weiskopf

Title: Daniela Weiskopf: Innovator in Dengue Virus Research

Introduction

Daniela Weiskopf is a prominent inventor based in San Diego, California. She has made significant contributions to the field of immunology, particularly in the development of vaccines against the Dengue virus. Her innovative work has the potential to impact public health positively.

Latest Patents

Weiskopf holds a patent for Dengue virus (DV) polypeptide sequences, T cell epitopes, and methods and uses thereof. This patent includes DV peptides, which consist of structural and non-structural polypeptide sequences, subsequences, and modifications. The patent also covers nucleotide sequences encoding these peptides and compositions that include them. These innovations can elicit and enhance anti-DV CD8T and CD4T cell responses, providing a foundation for vaccination and treatment methods against Dengue virus infections.

Career Highlights

Weiskopf is affiliated with the La Jolla Institute for Allergy and Immunology, where she conducts her research. Her work focuses on understanding the immune response to the Dengue virus and developing effective immunization strategies.

Collaborations

Some of her notable coworkers include Sujan Shresta and Lauren Yauch, who contribute to the research efforts at the La Jolla Institute.

Conclusion

Daniela Weiskopf's innovative research in the field of Dengue virus immunology exemplifies the critical role of inventors in advancing medical science. Her contributions are paving the way for new treatments and vaccines that could save lives.